Iron deficiency in Brazilian infants with sickle cell disease

Priscila C Rodrigues1, Rocksane C Norton, Mitiko Murao

  • 1Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG. Médica, Fundação Hemominas, Belo Horizonte, MG. Brazil. <vianamb@gmail.com>

Jornal De Pediatria
|August 16, 2011
PubMed

Insights

Most infants with sickle cell disease (SCD) do not have iron deficiency, but some do, especially those with SC hemoglobin. Iron supplementation may be considered but should stop after blood transfusions.

Area of Science:

  • Hematology
  • Pediatrics
  • Nutritional Science

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder.
  • Iron metabolism in infants with SCD requires careful monitoring.
  • Prophylactic iron supplementation guidelines for infants with SCD are not well-established.

Purpose of the Study:

  • To evaluate iron deficiency or overload in infants with SCD.
  • To inform decisions regarding prophylactic iron supplementation for this population.

Main Methods:

  • A cross-sectional and retrospective study of 135 infants under 2 years old with SS or SC hemoglobin.
  • Assessed iron status using mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), transferrin saturation (TS), and ferritin.
  • 12.6% of infants received blood transfusions before laboratory tests.

Main Results:

  • SC hemoglobin infants showed significantly lower ferritin and TS (p < 0.001).
  • 17.8% of infants met criteria for iron deficiency, predominantly those with SC hemoglobin (p = 0.003).
  • Iron deficiency was present in 19.5% of infants not transfused; elevated ferritin was observed in 11.3%, mostly transfused infants.

Conclusions:

  • Most infants with SCD do not develop iron deficiency, but a notable deficit exists in some.
  • Infants with SCD, particularly SC hemoglobin type, may benefit from prophylactic iron.
  • Iron supplementation should be discontinued following the first blood transfusion in infants with SCD.
Abstract

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

OverviewElements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally-occurring, and fewer still are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.The Periodic Table Provides Information...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...